Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 USD | -2.07% | -6.89% | -22.55% |
07-15 | Morgan Stanley Cuts Price Target on Vicarious Surgical to $10 From $18, Keeps Equalweight Rating | MT |
04-29 | Transcript : Vicarious Surgical Inc., Q1 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.55% | 51.15M | |
+3.75% | 208B | |
+7.69% | 182B | |
+29.03% | 155B | |
+35.12% | 115B | |
+2.78% | 66.52B | |
+14.82% | 53.93B | |
-6.47% | 46.26B | |
-3.53% | 38.22B | |
+6.14% | 36.6B |
- Stock Market
- Equities
- RBOT Stock
- News Vicarious Surgical Inc.
- Morgan Stanley Cuts Price Target on Vicarious Surgical to $10 From $18, Keeps Equalweight Rating